Qualigen Therapeutics Inc (QLGN)
3.90
-0.28
(-6.62%)
USD |
NASDAQ |
Nov 14, 12:27
Qualigen Therapeutics Shareholders Equity (Quarterly): -4.278M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -4.278M |
| March 31, 2024 | -3.522M |
| December 31, 2023 | -2.104M |
| September 30, 2023 | -1.641M |
| June 30, 2023 | 2.034M |
| March 31, 2023 | 4.869M |
| December 31, 2022 | 7.236M |
| September 30, 2022 | 12.15M |
| Date | Value |
|---|---|
| June 30, 2022 | 14.47M |
| March 31, 2022 | 13.52M |
| December 31, 2021 | 16.56M |
| September 30, 2021 | 10.85M |
| June 30, 2021 | 12.26M |
| March 31, 2021 | 16.23M |
| September 30, 2020 | -2.889M |
| June 30, 2020 | -13.15M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-13.15M
Minimum
Jun 2020
16.56M
Maximum
Dec 2021
5.162M
Average
6.053M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Protalix BioTherapeutics Inc | 28.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.5344M |
| Total Liabilities (Quarterly) | 4.812M |